Claret Capital Partners participates in €130m financing for Inventiva
Claret Capital Partners participates in €130m financing for Inventiva Inventiva is a clinical biopharmaceutical company developing an oral treatment for chronic liver disease, MASH Claret Capital Partners is providing growth funding of €43m as part of Inventiva’s €130m debt financing Latest in a series of late stage, European biotech investments by Claret Capital as part […]